World's Best Scientists 2026 revealed!
Award Badge
Best Scientists
2025
Award Badge
Medicine
UK
2026

D-Index & Metrics

Best Scientists

D-Index
172
Citations
165444
World Ranking
786
National Ranking
82

Medicine

D-Index
173
Citations
171772
World Ranking
463
National Ranking
55

Research.com Recognitions

  • 2026 - Research.com Medicine in United Kingdom Leader Award
  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Medicine in United Kingdom Leader Award
  • 2023 - Research.com Medicine in United Kingdom Leader Award

Overview

Keith A.A. Fox is affiliated with the University of Edinburgh in the United Kingdom. Their research is primarily situated within the field of Medicine, with a strong focus on Cardiology and Cardiovascular Medicine, Surgery, Internal Medicine, Radiology, Nuclear Medicine and Imaging, and Economics and Econometrics.

The work of Keith A.A. Fox encompasses several key topics, including:

  • Atrial Fibrillation Management and Outcomes
  • Acute Myocardial Infarction Research
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Venous Thromboembolism Diagnosis and Management
  • Cardiac Imaging and Diagnostics
  • Coronary Interventions and Diagnostics
  • Acute Ischemic Stroke Management

Frequent co-authors collaborating with Keith A.A. Fox include:

  • Karen S. Pieper
  • John W. Eikelboom
  • Saverio Virdone
  • A. John Camm
  • Salim Yusuf

The researcher has published extensively in a range of venues, particularly:

  • European Heart Journal
  • Circulation
  • Journal of the American College of Cardiology
  • European Heart Journal - Cardiovascular Pharmacotherapy
  • Open Heart

Notable recent papers by Keith A.A. Fox include:

  • Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis, 2021, The Lancet
  • Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study, 2022, The Lancet
  • Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis, 2021, The Lancet
  • Health-Related Quality of Life and Mortality in Heart Failure: The Global Congestive Heart Failure Study of 23 000 Patients From 40 Countries, 2021, Circulation
  • Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US, 2021, JAMA Cardiology

Best Publications

  • Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

    Manesh R. Patel;Kenneth W. Mahaffey;Jyotsna Garg;Guohua Pan

  • Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.

    Shamir R. Mehta;Salim Yusuf;Ron J. G. Peters;Michel E. Bertrand

  • Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events

    Deepak L. Bhatt;Keith A.A. Fox;Werner Hacke;Peter B. Berger

  • Universal definition of myocardial infarction.

    Kristian Thygesen;Joseph S. Alpert;Harvey D. White;Allan S. Jaffe

  • Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology.

    Frans Van de Werf;Jeroen Bax;Amadeo Betriu;Carina Blomstrom-Lundqvist

  • Predictors of hospital mortality in the global registry of acute coronary events.

    Christopher B. Granger;Robert J. Goldberg;Omar Dabbous;Karen S. Pieper

  • Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes

    J.P. Bassand;C.W. Hamm;D. Ardissino;E. Boersma

  • Plasma HDL cholesterol and risk of myocardial infarction: A mendelian randomisation study

    Benjamin F. Voight;Benjamin F. Voight;Benjamin F. Voight;Gina M. Peloso;Gina M. Peloso;Marju Orho-Melander;Ruth Frikke-Schmidt

  • Rivaroxaban in Patients with a Recent Acute Coronary Syndrome

    Jessica L. Mega;Eugene Braunwald;Stephen D. Wiviott;Jean-Pierre Bassand

  • ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.

    R Collins;R Peto;M Flather;S Parish

  • Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

    John W. Eikelboom;Stuart J. Connolly;Jackie Bosch;Gilles R. Dagenais

  • Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology.

    Frans Van de Werf;Diego Ardissino;Amadeo Betriu;Dennis V. Cokkinos

  • A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.

    M. Cohen;C. Demers;E. P. Gurfinkel;A. G. G. Turpie

  • A validated prediction model for all forms of acute coronary syndrome:estimating the risk of 6-month postdischarge death in an international registry

    Kim A Eagle;Michael J Lim;Omar H Dabbous;Karen S Pieper

  • Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)

    Keith A A Fox;Omar H Dabbous;Robert J Goldberg;Karen S Pieper

  • Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes: Phase Z of the A to Z Trial

    James A de Lemos;Michael A. Blazing;Stephen D. Wiviott;Eldrin F. Lewis

  • Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes

    John W. Eikelboom;Shamir R. Mehta;Sonia S. Anand;Changchun Xie

  • Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart)

    James Nolan;Phillip D. Batin;Richard Andrews;Steven J. Lindsay

  • Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI

    C Michael Gibson;Roxana Mehran;Christoph Bode;Jonathan Halperin

  • Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial.

    E. M. Antman;C. H. Mccabe;E. P. Gurfinkel;A. G. G. Turpie

Frequent Co-Authors

Graeme J. Hankey
Graeme J. Hankey University of Western Australia
Manesh R. Patel
Manesh R. Patel Duke University
Kenneth W. Mahaffey
Kenneth W. Mahaffey Stanford University
Jonathan P. Piccini
Jonathan P. Piccini Duke University
Scott D. Berkowitz
Scott D. Berkowitz University of Colorado Anschutz Medical Campus
Richard C. Becker
Richard C. Becker University of Cincinnati
Jonathan L. Halperin
Jonathan L. Halperin Icahn School of Medicine at Mount Sinai
Daniel E. Singer
Daniel E. Singer Harvard University
Deepak L. Bhatt
Deepak L. Bhatt Mount Sinai Hospital
Shaun G. Goodman
Shaun G. Goodman University of Toronto

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine doesn't always mean becoming a doctor. Many rewarding healthcare professions can be started or advanced through online study. For registered nurses looking for greater responsibility, adn to fnp programs provide a flexible route to becoming a Family Nurse Practitioner. These bridge programs allow you to build on your associate degree in nursing and move into advanced clinical roles.

For those interested in preventive health and dietary science, an online bachelor's in nutrition can open the door to careers in wellness coaching, public health, and clinical nutrition. These programs offer online flexibility while covering essential topics like metabolism and diet planning.

Healthcare management is another area of high demand. The best online mha programs are CAHME-accredited and designed for those aiming for leadership roles in hospitals, clinics, or healthcare systems. Many of these programs offer fully online coursework for working professionals.

Additionally, RNs seeking career advancement can find rn to bsn online with no clinicals options. These programs make it easier for nurses to earn their bachelor's degree without on-site clinical requirements, helping them step into higher-paying and more specialized nursing roles.

Best Scientists Citing Keith A.A. Fox

Trending Scientists

Recently Published Articles